SCIENCE IN SPORT PLC

Director's Dealing • Jun 12, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1340R

Science in Sport PLC

12 June 2018

12 June 2018

SCIENCE IN SPORT PLC

("SiS" or the "Company")

PDMR Dealing

The Company notifies that, further to the Exercise of Options announcement dated 21 May 2018, Ian Houghton, Commercial Director of the Company, has sold 81,500 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") at a price of 77 pence per Ordinary Share in order to satisfy the associated tax liability.

For further information:

Science in Sport plc	+44 (0) 20 7400 3700
Stephen Moon, CEO
Elizabeth Lake, FD
Cenkos Securities	+44 (0) 20 7397 8900
Max Hartley - NOMAD

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Ian Houghton
2	Reason for notification
a.	Position/Status	Commercial Director
b.	Initial notification/ Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Science in Sport PLC
b.	LEI	213800FWYWBJFJPPJ981
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary shares of 10p each ISIN: GB00BBPV5329
b.	Nature of the transaction	Sale of ordinary shares
c.	Price(s) and volume(s)
	Price(s)	Volume(s)
77 pence	81,500
d.	Aggregated information - Aggregated Volume - Price	81,500 £62,755.00
e.	Date of the transaction	2018-06-11
f.	Place of the transaction	AIMX

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBBGDLRBBBGID